Optometrists in Green Brook, NJ Accepting Medicare
10 Optometrists found. Showing 1 - 10
 Barrios Vision Llc Optometrist Medicare: Medicare Enrolled Practice Location: 221 Us Highway 22, Green Brook, NJ 08812 Phone: 732-968-4114 Fax: 732-968-6966 |
Christy T Hoang Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 215 Route 22 East, Green Brook, NJ 08812 Phone: 732-968-4114 |
 Dr. Pamela A Saus, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 255 Us Highway 22, Green Brook, NJ 08812 Phone: 732-752-6222 Fax: 732-752-2030 |
Jaime Rose Falco, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 255 Us Highway 22, Green Brook, NJ 08812 Phone: 732-752-6222 Fax: 732-752-2030 |
 Israel R Plasner, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 255 Us Hyw 22 East, Green Brook, NJ 08812 Phone: 732-752-6222 |
Christy Thuy Hoang, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 215 Us Highway 22 East, Green Brook, NJ 08812 Phone: 732-968-4114 Fax: 732-968-6966 |
Israel R Plasner Odpa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 255 Route 22 East, Green Brook, NJ 08812 Phone: 732-752-6222 Fax: 732-752-2030 |
Dr. Jeffrey James Ruffo, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 225 Rt 22 East, Green Brook, NJ 08112 Phone: 732-752-6222 Fax: 732-752-2030 |
Dr. Jesus L Barrios, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 221 Us Highway 22, Green Brook, NJ 08812 Phone: 732-968-4114 Fax: 732-968-6966 |
J Falco Od Llc Optometrist Medicare: Medicare Enrolled Practice Location: 255 Us Highway 22, Green Brook, NJ 08812 Phone: 732-752-6222 |
News Archive
Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease
A new subcutaneous formulation of RoActemra® (tocilizumab) has today been launched providing thousands of UK rheumatoid arthritis (RA) patients with a potentially life-changing treatment option.1
FoundationOne Heme identifies clinically actionable genomic alterations in multiple myeloma cases
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Provectus commences PH-10 Phase 2c trial for psoriasis
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has initiated a Phase 2c clinical trial of PH-10 for psoriasis. This multicenter, randomized controlled Phase 2c study is expected to enroll up to 90 subjects at four different sites, beginning in late December.
Poor environmental quality is linked to increased cancer incidence, say researchers
A new study has demonstrated an association between cancer incidence and poor environmental quality across U.S. counties. In counties where exposure to harmful environmental factors is highest, cancer rates are also highest, particularly the rates of breast cancer and prostate cancer.
› Verified 8 days ago
Optometrists
Chiropractors
Podiatrists
Occupational Therapists
Physical Therapists